top of page

Brent Saunders talks about his priorities for growth at Bausch + Lomb

He describes a recent deal Bausch + Lomb has made in dry eye disease and his goal to push further into retinal diseases as well.



Join the BiotechTV mailing list

Thanks for subscribing!

bottom of page